|
AU2016247232A1
|
|
Improved processes for making hydrazides
|
|
CN105579587A
|
|
Methods and compositions for cDNA synthesis and single-cell transcriptome profiling using template switching reaction
|
|
AU2014208212A1
|
|
Improved processes for making hydrazides
|
|
AU2014201308A1
|
|
Anti-IL-13 antibody formulations and uses thereof
|
|
AU2012275036A1
|
|
Bazedoxifene acetate formulations and manufacturing process thereof
|
|
AU2012244260A1
|
|
Tanaproget compositions containing ethinyl estradiol
|
|
AU2012209038A1
|
|
Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors
|
|
AU2012200929A1
|
|
High-dose, long-acting ectoparasiticide for extended control
|
|
AU2011224046A1
|
|
Multivalent avian influenza vaccines
|
|
AU2011203520A1
|
|
Micronized tanaproget and compostions containing same
|
|
WO2010138833A1
|
|
SUBSTITUTED IMIDAZO[1,5-a]QUINOXALINES AS INHIBITORS OF PHOSPHODIESTERASE 10
|
|
US2010120778A1
|
|
Quinoxaline-based lxr modulators
|
|
US2010120762A1
|
|
Triazine derivatives as inhibitors of phosphodiesterases
|
|
WO2010053986A1
|
|
Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (bhs) disease
|
|
WO2010036362A1
|
|
1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
|
|
US2010069340A1
|
|
Pharmaceutical compositions of an src kinase inhibitor and an aromatase inhibitor
|
|
US2010063023A1
|
|
Bicyclic and Tricyclic Substituted 6-Methylidene Carbapenems as Broad Spectrum Beta-Lactamase Inhibitors
|
|
CA2676881A1
|
|
Peripheral opioid receptor antagonists and uses thereof
|
|
GB0914826D0
|
|
Assay methods
|
|
TW201010719A
|
|
Immunological composition
|
